Clinical Trials Sponsored by Institut Curie Paris

Total 756 results

Institut Curie
Fondation Rothschild Paris

Active, not recruiting

Conservative Treatments of Retinoblastoma (RETINO2011)

Children | Retinoblastoma | Retinal Neoplasm

France
Institut Curie
Fondation Rothschild Paris

Recruiting

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome (RETINO2018)

Retinoblastoma

France
Assistance Publique - Hôpitaux de Paris
Institut Curie

Recruiting

Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2) (InnovRT-2)

ATRT

France
Institut Curie

Not yet recruiting

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) (FAP-IT)

Triple Negative Breast Cancer
Institut Curie

Recruiting

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours (BIOPORTAL)

Neuroblastoma | Ganglioneuroblastoma | Ganglioneuroma

France
Institut Curie

Recruiting

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) (SALOME)

Uveal Melanoma

France
Institut Curie

Recruiting

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH) (DepiSCARRH)

Hereditary Retinoblastoma

France
Institut Curie

Recruiting

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Retinoblastoma

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Ovarian Cancer

Ovarian Cancer

France
Institut Curie

Completed

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Uveal Melanoma

France
Institut Curie

Terminated

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

Metastatic Breast Cancer

France
Institut Curie

Completed

Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange. (CACTuS)

Cancer

France
Institut Curie

Completed

Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma (FibroRect)

Rectum Adenocarcinoma

France
Institut Curie

Completed

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification (PHRCNB07)

Neuroblastoma

France
Institut Curie

Active, not recruiting

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Uveal Melanoma | Melanoma, Uveal

France
Institut Curie

Terminated

FSH-R : Diagnostic Application for Localized Tumors in Cancerology (FRACTal)

Cancer

France
Institut Curie

Completed

Transcutaneous Breast Cancer Diagnosis by Canine Odorology (KDOG1)

Breast Cancer

France
Institut Curie

Completed

Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4) (BIO-RAIDs)

Cervical Cancer

France, Germany, Netherlands, Romania, Serbia
Institut Curie

Completed

Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial (ES4-UIC)

Metastatic Cancer | Clinical Trial | Supportive Care

France
Institut Curie

Completed

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology (DParcoursDig)

Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma) | Colorectal With Associated Risk Factors

France
Institut Curie

Completed

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives (GENEWING)

Sarcoma

France
Institut Curie

Completed

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer (KDOG2)

Breast Cancer | Surgery

France
Institut Curie

Completed

MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery (MIRs03)

Malignant Neoplasm of Breast

France
Institut Curie

Completed

Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer (CULTURE3D)

Colorectal Cancer

France
Institut Curie

Recruiting

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology (PEDIALOCK)

Children | Primary Prevention | Oncology | Medical Device

France
Institut Curie

Recruiting

Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2 (EORTC ICI)

Quality of Life | Cancer | IMMUNE CHECKPOINT INHIBITOR

France
Institut Curie

Recruiting

Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA (ALCYTA)

Cancer | Immune System or Toxicities Suspected

France
Institut Curie

Recruiting

Impact of Forearm Free Flap in Orbital Exenteration Reconstruction (REXOR)

Cancer

France
Institut Curie

Recruiting

Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy (NeoFit)

Breast Cancer

France
Institut Curie

Recruiting

Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology (ODORAJA)

Chemotherapy Effect | Solid Tumor, Adult | Solid Tumor, Childhood

France
Institut Curie

Recruiting

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. (PACT-01)

Carcinoma, Non-Small-Cell Lung | Advanced Cancer

France
Institut Curie

Recruiting

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG (LIBERTYLUNG)

NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor

France
Institut Curie

Recruiting

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC)

Thymoma Malignant Recurrent

France
Institut Curie

Recruiting

Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

Uveal Melanoma

France
Institut Curie

Recruiting

DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI)

Cancer Patients With Cancer Pain

France
Institut Curie

Recruiting

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

HPV Positive Pelvic Cancer

France
Institut Curie

Recruiting

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (MICCHADO)

Leukemia | Osteosarcoma | Neuroblastoma | Rhabdomyosarcoma | Central Nervous System Tumor | Ewing Sarcoma Family of Tumors

France
Institut Curie

Recruiting

COsegregation of VARiants in Panel of Genes (COVAR)

Genetic Predisposition | Gene Mutation-Related Cancer

France, Guadeloupe, Martinique, Réunion
Institut Curie

Completed

Study on Skin Toxicities Induced by Cancer Treatments (DERMACLIC)

Breast Cancer | Lung Cancer | Solid Tumor, Adult

France
Institut Curie

Active, not recruiting

Analysis of Circulating Tumor Markers in the Blood (ALCINA) (ALCINA)

Cancer

France
Institut Curie

Completed

Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), (NEO-ELASTO)

Breast Neoplasms

France
Institut Curie

Completed

Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)

Craniopharyngioma

France
Institut Curie

Completed

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

Women With BRCA1 Germline Deleterious Mutation

France
Institut Curie

Completed

Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (SIOP-PNET-4)

Medulloblastoma

France
Institut Curie

Active, not recruiting

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Neuroblastoma | Opsoclonus Myoclonus Syndrome

France, Austria, Italy, Spain, Sweden, Switzerland, United Kingdom
Institut Curie

Terminated

AsiDNA Children, Adolescents and Young Adults (AsiDNA)

Recurrent High-grade Glioma

France
Institut Curie

Completed

COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur (Curie-O-SA)

Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

France
Institut Curie

Completed

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer (HOTSHOT)

Breast Cancer

France
Institut Curie

Completed

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV)

Breast Cancer | Surgery

France
Institut Curie

Unknown

Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma (imMUno)

Uveal Melanoma

France

3

Subscribe